AbbVie Inc. is in talks to acquire next-generation psychedelics developer Gilgamesh Pharmaceuticals, according to people ...

A new meta-analysis comparing depression treatments finds that control groups in psilocybin trials show less improvement than ...

Since NeuroStar was the first TMS manufacturer to receive FDA clearance as an add-on therapy to treat adolescents, ages 15-21, with major depressive disorder in March 2024, we have seen over a ...

Dr. Jerome Adams says that if federal funding falters, many people could lose access to care, reversing hard-earned gains ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in pregnancy.

Despite the failure of its Recognify-partnered inidascamine, Jefferies analysts do not expect a definitively negative stock ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

I have a friend who goes to a ketamine clinic for fun. He doesn’t have depression or PTSD, but heard that ketamine was a ...

After drowning in his hot tub at 54, Matthew Perry's doctor pleaded guilty to distributing the drug that helped kill him.

Fragrance has entered the wellness and aromatherapy space. Discover the new scents designed to lower stress levels and ...

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new ...